NEFM and amyotrophic lateral sclerosis: Increased levels of NEFM have been detected in various neurological diseases, such as brain damage (Martínez-Morillo et al., 2015), schizophrenia spectrum disorders (Runge et al., 2022), and amyotrophic lateral sclerosis (Häggmark et al., 2014).